These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 367660)

  • 21. [Von Willebrand's disease--gene, molecule, clinical findings, treatment].
    Brosstad F
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2894-8. PubMed ID: 8236189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of von Willebrand's disease].
    Rafanelli D; Vannucchi AM; Morfini M
    G Clin Med; 1988 Jan; 69(1):63-6. PubMed ID: 3133271
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.
    Gazengel C; Fischer AM; Schlegel N; Rothschild C; Torchet MF; Dautzenberg MD; Aujard Y
    Nouv Rev Fr Hematol (1978); 1988; 30(4):225-7. PubMed ID: 3143100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of factor VIII levels after adrenalin in classic hemophilia and von Willebrand's disease (vWd).
    Eyster ME; Ballard JO; Prager D
    Thromb Haemost; 1978 Jun; 39(3):657-62. PubMed ID: 309190
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure - function relationship of factor VIII/von Willebrand factor. Application to the study of variant von Willebrand's disease and cryosupernatant prepared from normal plasma.
    Pietu G; Obert B; Larrieu MJ; Meyer D
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):671-85. PubMed ID: 6777898
    [No Abstract]   [Full Text] [Related]  

  • 27. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease.
    Holmbeg L; Nilsson IM
    Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo dissociation of factor VII (AHF) activity and factor VII-related antigen in von Willebrand's disease.
    Lian EC; Deykin D
    Am J Hematol; 1976; 1(1):71-8. PubMed ID: 1086597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Willebrand's disease: from discovery to therapy - milestones in the last 25 years.
    Kreuz W
    Haemophilia; 2008 Nov; 14 Suppl 5():1-2. PubMed ID: 18786005
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD
    Ann Clin Lab Sci; 1989; 19(3):184-9. PubMed ID: 2499240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 34. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 37. Cryoprecipitate transfusion in variant von Willebrand's disease and thrombocytopenia.
    Krizek DM; Rick ME; Williams SB; Gralnick HR
    Ann Intern Med; 1983 Apr; 98(4):484-6. PubMed ID: 6404206
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of von Willebrand's disease.
    Livingston RJ; White NS; Catone GA; Hartsock RJ
    J Oral Surg; 1974 Jan; 32(1):65-9. PubMed ID: 4543396
    [No Abstract]   [Full Text] [Related]  

  • 40. Von Willebrand's disease.
    Hoyer LW
    Prog Hemost Thromb; 1976; 3():231-87. PubMed ID: 781732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.